Menu

Tarsus Pharmaceuticals, Inc. TARS

Full chart Compare
Set alert

Price alert · TARS

All alert types
70.84 USD +2.24 (+3.27%)

At closeNov 9, 2026, 4:02 PM EST

70.84 0.00 0.00%

After hours · Nov 9, 4:02 PM ET

67.45 Day range 71.20
53.89 52-week range 91.53
YTD
-13.48%
1 year
+3.79%

Revenue & Expenses

Other Income → Expenses: $15.54MExpenses → Selling, General & Admin: $427.32MExpenses → Research & Development: $64.32MExpenses → Interest Expense: $8.94MExpenses → Income Tax: $2.06MGross Profit → Expenses: $420.68MRevenue → Gross Profit: $420.68MRevenue → Cost of Revenue: $30.68MNet Loss → Expenses: $66.42MOther Income$15.54MGross Profit$420.68MNet Loss$66.42MCost of Revenue$30.68MExpenses$502.64MSelling, General & Admin$427.32MResearch & Development$64.32MInterest Expense$8.94MIncome Tax$2.06MRevenue$451.36M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

TARS annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
451.36M182.95M17.45M25.82M57.03M
451.36M182.95M17.45M25.82M57.03M
30.68M12.83M1.59M955.00K2.08M
420.68M170.13M15.85M24.86M54.95M
491.64M290.70M159.01M87.57M67.11M
64.32M53.39M50.31M42.62M41.71M
427.32M237.31M108.70M44.95M25.40M
-70.97M-120.57M-143.16M-62.71M-12.16M
8.94M7.85M3.35M2.20M0
2.06M00-4.00K55.00K
-66.42M-115.55M-135.89M-62.09M-13.83M
-66.42M-115.55M-135.89M-62.09M-13.83M
-66.42M-115.55M-135.89M-62.09M-13.83M
-66.42M-115.55M-135.89M-62.09M-13.83M
-1.59-3.07-4.62-2.52-0.67
-1.59-3.07-4.62-2.52-0.67
-1.59-3.07-4.62-2.52-0.67
-55.42M-107.70M-132.55M-59.90M-13.77M
-55.42M-107.70M-132.55M-59.90M-13.77M
41.78M37.60M29.38M24.62M20.55M
41.78M37.60M29.38M24.62M20.55M